Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?

Department of Respiratory and Critical Care Medicine, Hôtel-Dieu Hospital, AP-HP, Université Paris Descartes, Paris, France.
Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K (Impact Factor: 9.38). 07/2008; 22(7):1361-7. DOI: 10.1038/leu.2008.100
Source: PubMed

ABSTRACT In patients with hematological malignancy (HM) developing acute respiratory failure (ARF) bronchoalveolar lavage (BAL) is considered as a major diagnostic tool. However, the benefit/risk ratio of this invasive procedure is probably lower in the subset of patients with acute myeloid leukemia (AML). The study was to analyze the yield of BAL performed in HM patients (n=175) with AML or lymphoid malignancies (LM) admitted in intensive care unit (ICU) for ARF and pulmonary infiltrates. BAL was performed in 121 patients (53/73 AML patients (73%) and 68/102 LM patients (67%)) without a definite diagnosis at admission or contraindication for fiberoptic bronchoscopy. Life-threatening complications were noticed in 12/121 patients (10%). The overall diagnostic yield of BAL was 47% (25/53) in AML patients and 50% (34/68) in LM patients. A microorganism was recovered from BAL in 23% (12/53) of AML patients and 41% (28/68) of LM patients (P<0.005). BAL results induced significant therapeutic changes in 17% (9/53) of AML patients vs 35% (24/68) of LM patients (P=0.039). This study underlines the rather low diagnostic yield of BAL for infectious diagnosis and the low rate of therapeutic changes induced by its results in AML patients with ARF admitted in ICU.

Download full-text


Available from: Antoine Rabbat, May 06, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The use of BAL to investigate the alveolar component of the patient’s lung has been widely developed since the mid 1970s; however the need for diagnostic BAL in patients with hematologic malignancies is considered to have decreased over the last 10 years. A major question in 2010 is therefore: what is the real value of BAL in everyday management of these patients? The aim of this chapter is to discuss clearly the various areas in which cytological examination of BAL fluid remains a particularly useful diagnostic tool in these patients. The diagnosis of pulmonary diseases associated with hematologic malignancies, such as pulmonary hemorrhage and pulmonary alveolar proteinosis, is based on BAL analysis not requiring pathologic examination of tissue samples. In primary lung lymphomas, BAL cytology is a particularly valuable first-line diagnostic procedure, and, in other situations, BAL cytology may make a major contribution to the diagnostic decision.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Partial discharge (PD) characteristics in air and argon in the 0.1-760 torr pressure range are reviewed for a needle-plane electrode arrangement. The test setup and various test results (PD inception voltage, waveforms, rise times) are discussed.
    Electrical Insulation and Dielectric Phenomena, 2004. CEIDP '04. 2004 Annual Report Conference on; 11/2004
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pneumocystis pneumonia remains one of the leading causes of morbidity and mortality among patients with acquired immunodeficiency syndrome (AIDS) all over the world [1]. However, pneumocystis pneumonia is also a life-threatening opportunistic infection that can occur in other immunocompromised patients, mainly in solid organ transplant recipients, in patients with cancer, and those treated for autoimmune or inflammatory diseases [1].
    12/2006: pages 157-170;